Burning Story

<div class='circular--portrait' style='background:#000000;color: #f2f2f2;font-size:4em;'>BR</div>
BNR -- USA Stock  

USD 36.30  1.07  2.86%

It seems Burning Rock will continue to recover much faster as its share price surged up 24.73% today. The company current daily volatility is 4.86 percent, with a beta of -0.01 and an alpha of 0.11 over DOW. As many millenniums are trying to avoid favorable retirement market, it makes sense to sum up Burning Rock Biotech a little further and try to understand its current market patterns. We will cover the possibilities of making Burning Rock into a steady grower in February.
Published over a month ago
View all stories for Burning Rock | View All Stories
How risky is Burning Rock Biotech after the latest volatility spike?
This firm runs under Healthcare sector within Diagnostics & Research industry. Our advice module can be used to complement Burning Rock investment recommendation provided by average analyst sentiment. It analyzes the company's potential to grow using fundamental, technical, data market data available at the time.
Investing in Burning Rock, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding Burning Rock along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Burning Rock's stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Burning Rock in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Burning Rock. Your research has to be compared to or analyzed against Burning Rock's peers to derive any actionable benefits. When done correctly, Burning Rock's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Burning Rock Biotech.

How Burning utilizes its cash?

To perform a cash flow analysis of Burning Rock, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Burning Rock is receiving and how much cash it distributes out in a given period. The Burning Rock cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Burning Rock Gross Profit

Burning Rock Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Burning Rock previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Burning Rock Gross Profit growth over the last 10 years.
Please check Gross Profit in more details.

Burning Rock Correlation with Peers

Investors in Burning can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in Burning Rock Biotech. Diversification will allow for the same portfolio return with reduced risk. The correlation table of Burning Rock and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities Burning is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage.
Please check volatility of Burning for more details

Breaking down the case for Burning Rock

Burning Rock appears to be not too volatile, given 1 month investment horizon. Burning Rock Biotech secures Sharpe Ratio (or Efficiency) of 0.0962, which signifies that the company had 0.0962% of return per unit of risk over the last month. Our standpoint towards foreseeing the volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Burning Rock Biotech, which you can use to evaluate future volatility of the firm. Please makes use of Burning Rock Biotech Downside Deviation of 3.9, risk adjusted performance of 0.0384, and Mean Deviation of 2.78 to double-check if our risk estimates are consistent with your expectations.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Our take on today Burning Rock spike

The expected short fall is down to -2.73 as of today. Burning Rock Biotech shows above-average downside volatility for the selected time horizon. We advise investors to inspect Burning Rock Biotech further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Burning Rock future alpha.

Our Final Takeaway

While many of the other players under the diagnostics & research industry are still a bit expensive, Burning Rock may offer a potential longer-term growth to retail investors. The inconsistency in the assessment between current Burning valuation and our trade advice on Burning Rock is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Burning Rock.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Burning Rock Biotech. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com